GlassScriptPhysician profile
Jeffrey Percey Smith
NPI 1215249586
$66,224.90
in general payments reported to CMS, 2019-2025
21 companies · $29K in 2025
The $29K reported for 2025 was more than what 93% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,991 · 2020: $4,997 · 2021: $2,136 · 2022: $4,963 · 2023: $14K · 2024: $8,736 · 2025: $29K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $34K · Travel and Lodging: $9,119 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,250 · Food and Beverage: $2,782.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $33,987.50 |
| Travel and Lodging | $9,119.06 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,250.00 |
| Food and Beverage | $2,781.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $42,557.88 | 2019-2025 | |
| Arthrex, INC. | $18,471.20 | 2019-2025 | |
| United Orthopedics LLC | $3,135.16 | 2022-2024 | |
| Stryker Corporation | $1,042.34 | 2022-2025 | Prostep Mica, Infinity Adaptis, Inbone |
| Biotissue Holdings INC. | $161.22 | 2025 | |
| Smith+Nephew, INC. | $147.97 | 2019 | |
| Ossdsign USA Incorporated | $147.84 | 2024 | |
| Medical Device Business Services, INC. | $109.52 | 2019 | |
| Medtronic, INC. | $100.81 | 2024 | Intellis Adaptivestim |
| Depuy Synthes Sales INC. | $94.30 | 2019-2025 | Na, Orthovisc |
| Ferring Pharmaceuticals INC. | $44.84 | 2023-2024 | Euflexxa |
| Forte Bio-Pharma LLC | $41.32 | 2020 | |
| Collegium Pharmaceutical, INC. | $29.50 | 2019 | |
| Sanara Medtech INC. | $24.12 | 2024 | Celleraterx |
| Avanos Medical | $21.33 | 2024 | Trivisc Sodium Hyaluronate |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $19.33 | 2021 | |
| Orthofix Medical, INC. | $17.31 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.11 | 2021 | |
| Fidia Pharma USA INC. | $15.91 | 2019 | |
| Abbvie INC. | $13.47 | 2023 | Ubrelvy |
| Horizon Therapeutics Plc | $12.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.